Peggy Scherle

Group Vice President of Discovery


Peggy Scherle

Peggy received her Ph.D. in immunology from the University of Pennsylvania and completed her postdoctoral training at the NIH. Prior to joining Incyte in 2002, Peggy held scientific research positions with DuPont Pharmaceuticals Company and Bristol-Myers Squibb. At Incyte, Peggy has been involved in target validation and drug discovery efforts within the therapeutic areas of inflammation and oncology. Her efforts have focused on the identification and preclinical characterization of small molecule inhibitors of key proteins involved in cell signaling and immune cell function.

Follow Peggy Scherle' at upcoming/ongoing conferences at gtcbio:

Immunotherapeutics & Immunomonitoring 2018